A Phase Ib Trial of Neoadjuvant AMG 232 Concurrent With Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2019
At a glance
- Drugs AMG 232 (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions
- 23 Nov 2018 Status changed from suspended to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 13 Aug 2018 Status changed from recruiting to suspended.